Natarajan Vijayasankaran
Advertisement
Natarajan Vijayasankaran is engineer II at late stage cell culture, US Biologics Pharma Technical Development, Genentech, Inc.
Articles by Natarajan Vijayasankaran
Advertisement
Latest Updated Articles
Systematic Approaches to Develop Chemically Defined Cell Culture Feed MediaPublished: November 1st 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
FAQ: Shifts in FDA Regulations and Strategies in 2025
4
Developing Next-Gen Cell Lines Using Targeted Integration
5
